The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

<div>Functionalization of the silicone hydrogel contact lenses: (a) methyl orange assay of APTES treated (top) and untreated (bottom) lenses showing the presence of NH<sub>2</sub> groups in the APTES treated lens and (b) BCA assay of peptide treated (top) and untreated (bottom) lenses showing the presence of peptide on the top lens.</div>

BioMed Research International

fig9

Figure 9

Figure 9: The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency 